U-Blot® Research Grade MuromonabCat. No. WA3196$9,999
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade MuromonabCat. No. WA3196
U-Blot® Research Grade MurlentamabCat. No. WA3195
U-Blot® Research Grade MupadolimabCat. No. WA3194
U-Blot® Research Grade MozistobartCat. No. WA3193
U-Blot® Research Grade MoxetumomabCat. No. WA3192
U-Blot® Research Grade MotavizumabCat. No. WA3191
U-Blot® Research Grade MosunetuzumabCat. No. WA3190
U-Blot® Research Grade MorolimumabCat. No. WA3189
U-Blot® Research Grade MORAb-028Cat. No. WA3188
U-Blot® Research Grade MOR202Cat. No. WA3187
U-Blot® Research Grade MOR106Cat. No. WA3186
U-Blot® Research Grade MOR106Cat. No. WA3185